These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6622211)

  • 21. Water-sorption properties of tablet disintegrants.
    Khan KA; Rhodes CT
    J Pharm Sci; 1975 Mar; 64(3):447-51. PubMed ID: 1151632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of disintegrant type upon the relationship between compressional pressure and dissolution efficiency.
    Khan KA; Rooke DJ
    J Pharm Pharmacol; 1976 Aug; 28(8):633-6. PubMed ID: 11313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the disintegration properties of microcrystalline cellulose II and commercial disintegrants.
    Rojas J; Kumar V
    Pharmazie; 2012 Jun; 67(6):500-6. PubMed ID: 22822537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of tablet disintegrants: impact of storage conditions and relative tablet density.
    Quodbach J; Kleinebudde P
    Pharm Dev Technol; 2015; 20(6):762-8. PubMed ID: 24848093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Simple and Inexpensive Image Analysis Technique to Study the Effect of Disintegrants Concentration and Diluents Type on Disintegration.
    Berardi A; Bisharat L; Blaibleh A; Pavoni L; Cespi M
    J Pharm Sci; 2018 Oct; 107(10):2643-2652. PubMed ID: 29935295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disintegrant Selection in Hydrophobic Tablet Formulations.
    Bauhuber S; Warnke G; Berardi A
    J Pharm Sci; 2021 May; 110(5):2028-2037. PubMed ID: 33181185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets.
    Zhao N; Augsburger LL
    AAPS PharmSciTech; 2005 Sep; 6(1):E120-6. PubMed ID: 16353956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An easy-to-use approach for determining the disintegration ability of disintegrants by analysis of available surface area.
    Iwao Y; Tanaka S; Uchimoto T; Noguchi S; Itai S
    Int J Pharm; 2013 May; 448(1):1-8. PubMed ID: 23518366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Native starch in tablet formulations: properties on compaction.
    Bos CE; Bolhuis GK; Van Doorne H; Lerk CF
    Pharm Weekbl Sci; 1987 Oct; 9(5):274-82. PubMed ID: 3432037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection of lubricant type and concentration for orodispersible tablets.
    Yi Zheng A; Teng Loh M; Wan Sia Heng P; Wah Chan L
    Int J Pharm; 2024 May; 657():124190. PubMed ID: 38701910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
    Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
    Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of a formulation for direct compression using a simplex lattice design.
    Van Kamp HV; Bolhuis GK; Lerk CF
    Pharm Weekbl Sci; 1987 Oct; 9(5):265-73. PubMed ID: 3432036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competing for water: A new approach to understand disintegrant performance.
    Ekmekciyan N; Tuglu T; El-Saleh F; Muehlenfeld C; Stoyanov E; Quodbach J
    Int J Pharm; 2018 Sep; 548(1):491-499. PubMed ID: 30018010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel approach of aceclofenac fast dissolving tablet.
    Dave V; Yadav S; Sharma S; Vishwakarma P; Ali N
    Pak J Pharm Sci; 2015 Jan; 28(1):37-41. PubMed ID: 25553683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
    Adeoye O; Alebiowu G
    Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach.
    Desai PM; Er PX; Liew CV; Heng PW
    AAPS PharmSciTech; 2014 Oct; 15(5):1093-104. PubMed ID: 24848762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissolution enhancement of an insoluble drug by physical mixture with a superdisintegrant: optimization with a simplex lattice design.
    Ferrari F; Bertoni M; Bonferoni CM; Rossi S; Caramella C; Bolhuis GK
    Pharm Dev Technol; 1996 Jul; 1(2):159-64. PubMed ID: 9552342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.